The Global Cardiac Rhythm Management Devices Market Analysis| Coherent Market Insights

1. Coherent Market Insights Market Research and Business Consulting Services https://www.coherentmarketinsights.com/ COVID-19 Impact Tracker

2. CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS Cardiac Rhythm Management Devices Market,byProduct Type (Cardiac Resynchronization Therapy Devices, Defibrillator, and Pacemakers), by End User (Hospitals, Home Care Settings, and Ambulatory Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026

3. Global Cardiac Rhythm Management Devices Market Revenue (US$ Bn) Analysis, By Product Type, 2017

4. Market Insights Cardiac Rhythm Management (CRM) devices include pacemakers (PMs), implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. These devices perform various functions, including bradycardia pacing, cardiac resynchronization for heart failure, monitoring for arrhythmias, defibrillation, and anti-tachycardia pacing for tachyarrhythmia. Products such as cardiac resynchronization therapy can improve congestive heart failure symptoms by improving the timing of the heart’s contractions, resulting in pumping more blood to the body. The global cardiac rhythm management devices market size was valued at US$ 19.05 billion in 2017, and is expected to witness a CAGR of 7.5% over the forecast period (2018 – 2026).

5. Market Drivers • Rising incidences of cardiac disorders worldwide is expected to drive the cardiac rhythm management devices market revenue • Rise in incidence of cardiovascular diseases such as cardiac arrhythmia, ischemic heart disease, and hypertension is expected to fuel growth of the cardiac rhythm management devices market. According to WHO report, in 2015, cardiovascular diseases was the leading cause of deaths accounting for 17.7 million deaths, worldwide.

6. Furthermore, technological advancements in cardiac rhythm management devices is the major growth rendering factor for the industry. For instance, adoption of advanced technologies in cardiac pacemakers such as pacemakers with improved battery life and MRI safe-pacemakers, delay the progression of persistent atrial fibrillation (AF) in patients suffering from bradycardia. These advancements are gaining significant traction and are expected to fuel the demand for cardiac rhythm management devices. For instance, in February 2017, Abbott received the Food and Drug Administration (FDA) approval for its MR-conditional labeling for Assurity MRI pacemaker and the Tendril MRI pacing lead. • Moreover, introduction of remote technology in cardiac rhythm management devices is anticipated to drive market growth. Remote technology includes remote follow-up, in which data can be periodically downloaded from the device, either through patient interaction with a transmitter system or automatically with no patient participation. The technology allows clinicians to perform periodic routine patient check-ups remotely.

7. Global Cardiac Rhythm Management Devices Market Share (%), By Region, 2017

8. Market Restraints Despite tremendous rise in cardiac rhythm disorders worldwide, implantable pacemakers associated infections in cardiac patients can deter patients from using the products, negatively impacting growth of the cardiac rhythm management devices market. Many manufacturers in the industry are claiming risks associated with their products. For instance, according to the Medtronic, risks associated with an ICD implant include, infection at the surgical site and/or sensitivity to the device material, failure to deliver therapy when it is needed, and receiving extra therapy when it is not needed. Moreover, after receiving an ICD, patient will have limitations with respect to electromagnetic and magnetic radiation, and gas or electric-powered appliances.

9. Regioanal Insights • On the basis of region, the global cardiac rhythm management devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in global cardiac rhythm management devices market during the forecast period, due to increasing prevalence of cardiovascular diseases in the region. According to the American Heart Association (AHA), 2017, around 92.1 million adults in the U.S. are suffering from some form of cardiovascular disease or the after-effects of stroke. AHA report also stated that direct and indirect costs of cardiovascular diseases and stroke are estimated to account for US$ 316 billion, including health expenditures and lost productivity.

10. Asia Pacific cardiac rhythm management devices market is expected to witness lucrative growth during the forecast years, owing to high demand for technological advanced products for cardiac rhythm management coupled with rising healthcare concern for stroke prevention associated with atrial fibrillation. According to the Japanese Heart Rhythm Society in 2017, the Asian population with atrial fibrillation (AF) is estimated to reach 72 million by 2050, of which 2.9 million may suffer from AF-associated strokes.

11. Competitive Section Key players operating in the global cardiac rhythm management devices market include Medtronic plc. Abbott Laboratories, Abiomed, Boston Scientific Corporation, Biotronik Se Co Kg, Koninklijke Philips N.V., LivaNovaPlc, Cardiac Science Corporation, Schiller Ag, and Zoll Medical Corporation.

12. Request Sample Report • Request Customization • Download PDF Brochure • Talk to Analyst Reference: https://www.coherentmarketinsights.com/market-insight/cardiac-rhythm-management-devices-market-2364

13. About Us Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. What we provide: • Customized Market Research Services • Industry Analysis Services • Business Consulting Services • Market Intelligence Services • Long term Engagement Model • Country Specific Analysis

14. Contact Us Mr. Shah Coherent Market Insights Pvt.Ltd. Address: 1001 4th Ave, #3200 Seattle, WA 98154, U.S. Phone: +1-206-701-6702 Email: sales@coherentmarketinsights.com

15. Thank You! Kindly follow CMI Social Media Profiles for the latest company updates Facebook Linkedin Twitter https://www.coherentmarketinsights.com/